Clinical trial
ARREST PAD (Peripheral Arterial Disease)
NCT00153166 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00153166 |
|---|---|
| Title | ARREST PAD (Peripheral Arterial Disease) |
| Official title | The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Disease, Intermittent Claudication, Insulin Resistance |
| Intervention type | Drug |
| Interventions | atorvastatin and pioglitazone, atorvastatin/placebo, pioglitazone/placebo, placebo/placebo |
| Enrollment | 76 |
| Start date | Jan 1, 2004 |
| Primary completion | Nov 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 30, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: